bioAffinity Technologies, Inc.
BIAFW- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001712762
No open-market purchases or sales by bioAffinity Technologies, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $18.1K in total; no superinvestor holds it.
Other share classesBIAF
Holders of 5% or more of BIAFW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of bioAffinity Technologies, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of bioAffinity Technologies, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on bioAffinity Technologies, Inc., newest first.
No Schedule 13D or 13G filings on bioAffinity Technologies, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell bioAffinity Technologies, Inc. shares.
No Form 144 notices for bioAffinity Technologies, Inc. are on file.